课题基金 / 基金详情

PA-20-070 Improving Medication Safety and Nursing Workflow during COVID Through eMAR Redesign

PA-20-070 Improving Medication Safety and Nursing Workflow during COVID Through eMAR Redesign
PA-20-070 通过 eMAR 重新设计改善新冠肺炎期间的用药安全和护理工作流程
批准号:
10175229
负责人:
Raj M Ratwani
金额:
$24.53万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2023-04-30

项目摘要

项目成果

Raj M Ratwani的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要/摘要 建议的研究是对AHRQ PA-20-070的直接回应。我们的目标是支持护理工作流程和 减少与电子用药记录(EMAR)相关的患者安全风险 新冠肺炎等流行病通过:(1)了解新冠肺炎和新冠肺炎前的用药管理 通过分析卫生信息技术和虚拟访谈护士的工作流程;和(2) 开发并向医疗机构传播用药管理工作流程风险评估工具 和健康信息技术测试案例,以评估eMAR的可用性和安全性。我们将发展一种广泛的 了解用药流程变化和健康信息技术需求 通过比较与药物相互作用产生的电子数据,在新冠肺炎期间 管理技术这些各自的时间段。然后我们将与护士进行面谈,以 验证用药工作流程,并生成流程图以比较新冠肺炎实施前和 新冠肺炎的用药管理工作流程旨在识别安全风险。这些数据将告诉我们 开发风险评估工具和可用性测试用例,以传播到医疗机构 和技术供应商。 该项目利用了研究团队在人为因素、健康信息方面的广泛专业知识 技术、信息学和数据科学,以及安全科学。我们的研究团队包括医生、护士、 以及人为因素工程师。该提案涉及征求建议书的基本方面,具体如下 提供有关用药安全和健康信息技术的新见解,以解决 新冠肺炎等流行病的挑战。这项研究的贡献将包括一个基本的 了解卫生信息技术在用药过程中的作用,重点是 医疗系统和医疗系统风险评估工具和测试用例的信息流、设计和开发 技术供应商应对新冠肺炎期间患者安全面临的更多风险。
英文摘要
PROJECT SUMMARY/ABSTRACT The proposed research is in direct response to AHRQ PA-20-070. We aim to support nursing workflow and reduce patient safety hazards associated with electronic medication administration records (eMARs) during pandemics such as COVID-19 by: (1) understanding pre-COVID-19 and COVID-19 medication administration workflows through analysis of health information technology and virtual interviews with nurses; and (2) developing and disseminating a medication administration workflow risk assessment tool to healthcare facilities and health information technology test cases to assess eMAR usability and safety. We will develop a broad understanding of medication administration workflow changes and health information technology needs pre COVDI-19 and during COVID-19 by comparing electronic data generated in interactions with medication administration technology these respective time periods. We will then conduct interviews with nurses to validate the medication administration workflows, and generate process maps to compare pre-COVID-19 vs. COVID-19 medication administration workflows with the goal of identifying safety risks. These data will inform the development of the risk assessment tool and usability test cases to be disseminated to healthcare facilities and technology vendors. This project utilizes the extensive expertise of the research team in human factors, health information technology, informatics and data science, and safety science. Our research team includes physicians, nurses, and human factors engineers. The proposal addresses fundamental aspects of the call for proposals by providing new insights on medication administration safety and health information technology to address challenges of pandemics such as COVID-19. Contributions from this research will include a fundamental understanding of the role of health information technology during medication administration with a focus on information flow, design, and development of a risk assessment tool and test cases for healthcare systems and technology vendors to meet the increased risks to patient safety during COVID-19.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transforming Patient Safety Event Data into Actionable Insights through Advanced Analytics
Transforming Patient Safety Event Data into Actionable Insights through Advanced Analytics
Transforming Patient Safety Event Data into Actionable Insights through Advanced Analytics
Improving Patient Safety and Clinician Cognitive Support Through eMAR Redesign
国内基金
海外基金
CDC20-HDAC6-POLD1轴调控肺腺癌免疫微环境的机制研究
  • 批准号:
    2026JJ80369
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    胡智
  • 依托单位:
CCL20/CCR6/SEMA3C信号轴通过EMT及肿瘤干细胞互作调控阴茎癌转移的分子机制研究
  • 批准号:
    2026JJ50313
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    胡希恒
  • 依托单位:
USP20调控泛素化修饰介导微卫星稳定型结直肠癌免疫逃逸的机制研究
巴多昔芬通过重编程肿瘤相关巨噬细胞抑制CCL20介导的Treg募集并增敏乳腺癌免疫治疗的机制研究
  • 批准号:
    JCZRQNB202600315
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: